vs

Side-by-side financial comparison of Stock Yards Bancorp, Inc. (SYBT) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

Zai Lab Ltd is the larger business by last-quarter revenue ($127.1M vs $104.4M, roughly 1.2× Stock Yards Bancorp, Inc.). On growth, Zai Lab Ltd posted the faster year-over-year revenue change (17.1% vs 11.7%). Stock Yards Bancorp, Inc. produced more free cash flow last quarter ($154.0M vs $-26.7M). Over the past eight quarters, Zai Lab Ltd's revenue compounded faster (20.8% CAGR vs 11.9%).

Community Trust Bancorp is an American regional bank holding company that was founded in 1903 as Pikeville National Bank. The renamed corporation continues to have its headquarters in Pikeville, Kentucky, at the heart of Appalachia. Community Trust Bancorp operates a commercial bank, Community Trust Bank, and a trust company, Community Trust and Investment Company of Lexington.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

SYBT vs ZLAB — Head-to-Head

Bigger by revenue
ZLAB
ZLAB
1.2× larger
ZLAB
$127.1M
$104.4M
SYBT
Growing faster (revenue YoY)
ZLAB
ZLAB
+5.5% gap
ZLAB
17.1%
11.7%
SYBT
More free cash flow
SYBT
SYBT
$180.7M more FCF
SYBT
$154.0M
$-26.7M
ZLAB
Faster 2-yr revenue CAGR
ZLAB
ZLAB
Annualised
ZLAB
20.8%
11.9%
SYBT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SYBT
SYBT
ZLAB
ZLAB
Revenue
$104.4M
$127.1M
Net Profit
$36.6M
Gross Margin
51.0%
Operating Margin
45.9%
-54.6%
Net Margin
35.1%
Revenue YoY
11.7%
17.1%
Net Profit YoY
15.5%
EPS (diluted)
$1.24
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SYBT
SYBT
ZLAB
ZLAB
Q4 25
$104.4M
$127.1M
Q3 25
$101.5M
$115.4M
Q2 25
$97.8M
$109.1M
Q1 25
$93.5M
$105.7M
Q4 24
$93.5M
$108.5M
Q3 24
$89.8M
$101.8M
Q2 24
$85.7M
$100.1M
Q1 24
$83.3M
$87.1M
Net Profit
SYBT
SYBT
ZLAB
ZLAB
Q4 25
$36.6M
Q3 25
$36.2M
$-36.0M
Q2 25
$34.0M
$-40.7M
Q1 25
$33.3M
$-48.4M
Q4 24
$31.7M
Q3 24
$29.4M
$-41.7M
Q2 24
$27.6M
$-80.3M
Q1 24
$25.9M
$-53.5M
Gross Margin
SYBT
SYBT
ZLAB
ZLAB
Q4 25
51.0%
Q3 25
59.5%
Q2 25
60.6%
Q1 25
63.6%
Q4 24
61.5%
Q3 24
64.1%
Q2 24
64.9%
Q1 24
61.4%
Operating Margin
SYBT
SYBT
ZLAB
ZLAB
Q4 25
45.9%
-54.6%
Q3 25
45.0%
-42.3%
Q2 25
43.9%
-50.3%
Q1 25
44.5%
-53.3%
Q4 24
41.9%
-62.6%
Q3 24
41.2%
-66.6%
Q2 24
41.2%
-76.0%
Q1 24
39.5%
-80.7%
Net Margin
SYBT
SYBT
ZLAB
ZLAB
Q4 25
35.1%
Q3 25
35.7%
-31.2%
Q2 25
34.8%
-37.3%
Q1 25
35.6%
-45.8%
Q4 24
33.9%
Q3 24
32.7%
-40.9%
Q2 24
32.2%
-80.2%
Q1 24
31.1%
-61.4%
EPS (diluted)
SYBT
SYBT
ZLAB
ZLAB
Q4 25
$1.24
$-0.05
Q3 25
$1.23
$-0.03
Q2 25
$1.15
$-0.04
Q1 25
$1.13
$-0.04
Q4 24
$1.07
$-0.09
Q3 24
$1.00
$-0.04
Q2 24
$0.94
$-0.08
Q1 24
$0.88
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SYBT
SYBT
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$689.6M
Total DebtLower is stronger
$26.8M
Stockholders' EquityBook value
$1.1B
$715.5M
Total Assets
$9.5B
$1.2B
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SYBT
SYBT
ZLAB
ZLAB
Q4 25
$689.6M
Q3 25
$717.2M
Q2 25
$732.2M
Q1 25
$757.3M
Q4 24
$779.7M
Q3 24
$616.1M
Q2 24
$630.0M
Q1 24
$650.8M
Total Debt
SYBT
SYBT
ZLAB
ZLAB
Q4 25
$26.8M
Q3 25
$26.8M
Q2 25
Q1 25
$26.8M
Q4 24
$26.8M
Q3 24
$26.8M
Q2 24
$26.8M
Q1 24
$26.8M
Stockholders' Equity
SYBT
SYBT
ZLAB
ZLAB
Q4 25
$1.1B
$715.5M
Q3 25
$1.0B
$759.9M
Q2 25
$1.0B
$791.7M
Q1 25
$975.5M
$810.8M
Q4 24
$940.5M
$840.9M
Q3 24
$934.1M
$667.7M
Q2 24
$894.5M
$704.2M
Q1 24
$874.7M
$762.2M
Total Assets
SYBT
SYBT
ZLAB
ZLAB
Q4 25
$9.5B
$1.2B
Q3 25
$9.3B
$1.2B
Q2 25
$9.2B
$1.2B
Q1 25
$9.0B
$1.2B
Q4 24
$8.9B
$1.2B
Q3 24
$8.4B
$985.3M
Q2 24
$8.3B
$987.4M
Q1 24
$8.1B
$988.4M
Debt / Equity
SYBT
SYBT
ZLAB
ZLAB
Q4 25
0.02×
Q3 25
0.03×
Q2 25
Q1 25
0.03×
Q4 24
0.03×
Q3 24
0.03×
Q2 24
0.03×
Q1 24
0.03×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SYBT
SYBT
ZLAB
ZLAB
Operating Cash FlowLast quarter
$166.0M
$-26.0M
Free Cash FlowOCF − Capex
$154.0M
$-26.7M
FCF MarginFCF / Revenue
147.5%
-21.0%
Capex IntensityCapex / Revenue
11.5%
0.5%
Cash ConversionOCF / Net Profit
4.54×
TTM Free Cash FlowTrailing 4 quarters
$260.5M
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SYBT
SYBT
ZLAB
ZLAB
Q4 25
$166.0M
$-26.0M
Q3 25
$38.2M
$-32.0M
Q2 25
$55.9M
$-31.0M
Q1 25
$19.8M
$-61.7M
Q4 24
$142.9M
$-55.8M
Q3 24
$55.4M
$-26.8M
Q2 24
$51.1M
$-42.2M
Q1 24
$17.4M
$-90.1M
Free Cash Flow
SYBT
SYBT
ZLAB
ZLAB
Q4 25
$154.0M
$-26.7M
Q3 25
$35.2M
$-35.0M
Q2 25
$53.5M
$-33.9M
Q1 25
$17.8M
$-63.2M
Q4 24
$133.0M
$-58.4M
Q3 24
$53.9M
$-28.2M
Q2 24
$47.9M
$-42.9M
Q1 24
$15.6M
$-91.1M
FCF Margin
SYBT
SYBT
ZLAB
ZLAB
Q4 25
147.5%
-21.0%
Q3 25
34.6%
-30.4%
Q2 25
54.7%
-31.1%
Q1 25
19.1%
-59.9%
Q4 24
142.3%
-53.8%
Q3 24
60.0%
-27.7%
Q2 24
55.9%
-42.9%
Q1 24
18.7%
-104.5%
Capex Intensity
SYBT
SYBT
ZLAB
ZLAB
Q4 25
11.5%
0.5%
Q3 25
3.0%
2.6%
Q2 25
2.5%
2.6%
Q1 25
2.1%
1.5%
Q4 24
10.5%
2.4%
Q3 24
1.7%
1.3%
Q2 24
3.8%
0.7%
Q1 24
2.2%
1.1%
Cash Conversion
SYBT
SYBT
ZLAB
ZLAB
Q4 25
4.54×
Q3 25
1.05×
Q2 25
1.64×
Q1 25
0.59×
Q4 24
4.51×
Q3 24
1.89×
Q2 24
1.85×
Q1 24
0.67×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SYBT
SYBT

Segment breakdown not available.

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons